Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus

被引：22
|
作者：
Wierzbicki, AS [1 ]
机构：
[1] Kings Coll London, Guys Kings & St Thomas Med Sch, St Thomas Hosp, Dept Chem Pathol, London SE1 7EH, England
来源：
LUPUS | 2000年 / 9卷 / 03期
关键词：
systemic lupus erythematosus; atherosclerosis; cardiovascular disease; lipids; apolipoproteins;
D O I：
10.1191/096120300678828235
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Systemic lupus erythematosus is commonly associated with early onset cardiovascular disease and is often associated with hyperlipidaemia. This review examines the evidence for an increased prevalence of both CHD and hyperlipidaemia in SLE and mechanisms by which autoimmunity in SLE could accelerate the progression of atheroma. It postulates how lipid lowering therapies used in cardiological disease might help reduce the incidence of CHD in SLE.
引用
收藏
页码：194 / 201
页数：8
相关论文
共 50 条
  • [1] Markers of atherosclerosis and cardiovascular disease in patients with systemic lupus erythematosus
    Rednic, S
    Damian, LO
    Minodora, M
    Cristea, A
    Bolosiu, HD
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 436 - 436
  • [2] Systemic lupus erythematosus and cardiovascular disease
    Ruilope, Luis M.
    Ruiz-Hurtado, G.
    [J]. INTERNATIONAL JOURNAL CARDIOLOGY HYPERTENSION, 2020, 7
  • [3] Systemic lupus erythematosus and cardiovascular disease
    Frostegard, Johan
    [J]. JOURNAL OF INTERNAL MEDICINE, 2023, 293 (01) : 48 - 62
  • [4] Systemic lupus erythematosus and cardiovascular disease
    Jiménez, S
    Font, J
    Ingelmo, M
    [J]. MEDICINA CLINICA, 2002, 119 (18): : 699 - 706
  • [5] Cardiovascular disease in systemic lupus erythematosus
    McMahon, Maureen
    Seto, Richard
    Skaggs, Brian J.
    [J]. RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2021, 2 (03): : 157 - 172
  • [6] Systemic Lupus Erythematosus and Cardiovascular Disease
    Jha, Surajkumar B.
    Rivera, Ana P.
    Monar, Gabriela Vanessa Flores
    Islam, Hamza
    Puttagunta, Sri Madhurima
    Islam, Rabia
    Kundu, Sumana
    Sange, Ibrahim
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [7] Systemic lupus erythematosus and cardiovascular disease
    Frostegard, J.
    [J]. LUPUS, 2008, 17 (05) : 364 - 367
  • [8] Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies
    Hahn, B. H.
    McMahon, M.
    [J]. LUPUS, 2008, 17 (05) : 368 - 370
  • [9] ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS. EFFECTS OF STATINS TREATMENT
    Barbarroja, N.
    Ruiz-Limon, P.
    Perez-Sanchez, C.
    Aguirre, M. A.
    Khamastha, M. A.
    Rodriguez-Ariza, A.
    Gonzalez-Reyes, J. A.
    Kraiwesh, H.
    Villalba-Montoro, J. M.
    Collantes-Estevez, E.
    Cuadrado, M. J.
    Lopez-Pedrera, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 865 - 865
  • [10] Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment
    Ruiz-Limon, Patricia
    Barbarroja, Nuria
    Perez-Sanchez, Carlos
    Angeles Aguirre, Maria
    Laura Bertolaccini, Maria
    Khamashta, Munther A.
    Rodriguez-Ariza, Antonio
    Almaden, Yolanda
    Segui, Pedro
    Khraiwesh, Husam
    Antonio Gonzalez-Reyes, Jose
    Manuel Villalba, Jose
    Collantes-Estevez, Eduardo
    Jose Cuadrado, Maria
    Lopez-Pedrera, Chary
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (07) : 1450 - 1458
12345